You have 1 free disease view remaining today. Register for more view, it is 100% free →
retinal macular dystrophy
Description
Retinal Macular Dystrophy: A Rare Genetic Eye Disorder
Retinal macular dystrophy, also known as macular dystrophy, is a rare genetic eye disorder that causes significant visual loss due to progressive damage to the retina. This condition affects the macula, a specific portion of the retina responsible for central vision.
Causes and Characteristics
Macular dystrophy is an inherited retinal disease caused by mutations in various genes, leading to premature aging and cell death in the macula [3]. The disorder can manifest in different forms, including autosomal dominant (ADD) and autosomal recessive patterns of inheritance [5].
Symptoms and Types
The symptoms of macular dystrophy may vary depending on the type and severity of the condition. Some common features include:
- Central vision loss
- Blurred or distorted vision
- Difficulty with reading, driving, or other activities requiring clear central vision
There are several types of juvenile macular dystrophy, including Best's disease (also called Best's vitelliform retinal dystrophy) and juvenile retinoschisis [8].
Prevalence and Impact
Macular dystrophies are a group of rare genetic eye conditions that cause significant visual loss. According to some sources, these inherited retinal diseases affect a substantial number of people worldwide [2]. The impact of macular dystrophy on daily life can be profound, affecting not only the individual but also their family and caregivers.
References
[1] WebMD (2024) - Macular Dystrophy: A Rare Genetic Eye Disorder [2] N Rahman et al. (2020) - Macular Dystrophies: A Review of the Literature [3] Macular Dystrophy: A Heritable Disorder [Context 3] [5] Autosomal Dominant Condition Characterised by Drusen-Like Deposits [Context 5] [8] Other Types of Juvenile Macular Dystrophy [Context 8]
Note: The references provided are based on the search results and may not be an exhaustive list of all relevant sources.
Additional Characteristics
- Retinal macular dystrophy, also known as macular dystrophy, is a rare genetic eye disorder that causes significant visual loss due to progressive damage to the retina.
- Macular dystrophy is an inherited retinal disease caused by mutations in various genes, leading to premature aging and cell death in the macula.
- Macular dystrophies are a group of rare genetic eye conditions that cause significant visual loss.
- The symptoms of macular dystrophy may vary depending on the type and severity of the condition. Some common features include: central vision loss, blurred or distorted vision, difficulty with reading, driving, or other activities requiring clear central vision.
Signs and Symptoms
Common Signs and Symptoms of Retinal Macular Dystrophy
Retinal macular dystrophy, also known as macular retinal dystrophy, is a rare genetic eye disorder that causes vision loss. The symptoms can vary from person to person, but here are some common signs and symptoms associated with this condition:
- Visual Distortions: Straight lines may appear bent or wavy [3][9]
- Reduced Central Vision: Difficulty seeing objects clearly in the center of your vision, which can affect one or both eyes [3][9]
- Increased Light Sensitivity: Needing brighter light to read or perform other visual tasks [3][4]
- Black Spots in Central Vision: Dark spots or blind spots in the center of your vision [2][4][7]
- Difficulty with Reading Small Print: Trouble reading small print, words on magazines, or other visual materials [7]
It's essential to note that these symptoms can be similar to those experienced by people with macular degeneration. If you're experiencing any of these symptoms, it's crucial to consult an eye doctor for a proper diagnosis and treatment plan.
References:
- [1] Macular retinal dystrophy is a rare genetic eye disorder that causes vision loss.
- [2] Black spots in your central vision
- [3] Symptoms · Visual distortions, such as straight lines seeming bent. · Reduced central vision in one or both eyes. · The need for brighter light when reading or ...
- [4] Feb 28, 2022 — Symptoms of Macular Dystrophy · Black spots in your central vision · Lines appearing to be bent or wavy · Increased light sensitivity · Shapes and ...
- [7] Jul 18, 2012 — The most common macular degeneration symptoms are blurring in the centre of your vision and distortion.
- [9] Symptoms · Visual distortions, such as straight lines seeming bent. · Reduced central vision in one or both eyes. · The need for brighter light when reading or ...
Additional Symptoms
- Visual Distortions
- Reduced Central Vision
- Increased Light Sensitivity
- Black Spots in Central Vision
- Difficulty with Reading Small Print
Diagnostic Tests
Diagnostic Tests for Retinal Macular Dystrophy
Retinal macular dystrophy, also known as inherited retinal disease (IRD), is a group of rare genetic disorders that affect the retina and can lead to vision loss. Accurate diagnosis is crucial for managing these conditions effectively.
- Optical Coherence Tomography (OCT): This non-invasive imaging technique produces cross-sectional images of the retina, allowing doctors to identify areas of thinning, thickening, or swelling [2][3]. OCT scans can help monitor how the retina changes over time and are often used in combination with other tests.
- Fluorescein Angiography: This diagnostic test involves injecting a special dye into a vein in the arm, which highlights blood vessels in the retina. It is particularly useful for detecting wet age-related macular degeneration [9].
- Fundus Photos: These photographs of the retina can help doctors identify changes and monitor progression over time [8].
- Retinal Photography: Some optometrists use photography or other imaging techniques to detect early signs of retinal macular dystrophy, including OCT scans [2][7].
Additional Tests
In addition to these tests, a complete eye exam, medical history review, and family history assessment may also be conducted to diagnose retinal macular dystrophy. A combination of clinical exams and specific tests, such as angiography and optical coherence tomography, can provide an accurate diagnosis [5].
Additional Diagnostic Tests
- Optical Coherence Tomography (OCT)
- Retinal Photography
- Fluorescein Angiography
- Fundus Photos
Treatment
Treatment Options for Retinal Macular Dystrophy
Retinal macular dystrophy, also known as macular degeneration, is a group of eye disorders that can cause vision loss and blindness. While there are no cures for these conditions, various treatments can help slow down or stabilize the progression of the disease.
Anti-VEGF Drugs
One common treatment approach for retinal macular dystrophy is the use of anti-VEGF (vascular endothelial growth factor) drugs. These medications work by reducing the growth of new blood vessels in the retina, which can prevent further vision loss [5][7]. Anti-VEGF drugs such as Lucentis (ranibizumab), Eylea (aflibercept), Beovu (Brolucizumab), and Vabysmo (faricimab) are commonly used to treat wet macular degeneration, a more aggressive form of the disease [3].
Other Treatment Options
In addition to anti-VEGF drugs, other treatment options for retinal macular dystrophy include:
- Photodynamic therapy (PDT): This treatment uses a light-sensitive medication and a laser to destroy abnormal blood vessels in the retina [2].
- Laser surgery: This procedure can help reduce vision loss by destroying abnormal blood vessels in the retina.
- AREDS2 supplement: This dietary supplement has been shown to slow down the progression of age-related macular degeneration, which is a common cause of retinal macular dystrophy [8].
Experimental Treatments
Researchers are also exploring new and experimental treatments for retinal macular dystrophy. For example, an experimental drug called CY-09 has been found to block the inflammatory process that drives dry AMD by binding to a molecule called NLRP3 [6]. Another experimental treatment, pegcetacoplan (Syfovre), has shown promise in slowing down the progression of retinal macular dystrophy.
Recent FDA Approval
In 2023, the FDA approved a new treatment for macular degeneration known as IZERVAY™, formerly Zimura. This drug works by blocking the effects of growth signals that promote the formation of abnormal blood vessels in the retina [4].
It's essential to note that each individual's experience with retinal macular dystrophy can vary greatly, and treatment options may depend on the specific type and severity of the disease.
References:
[1] Not provided (no relevant information found)
[2] Sep 18, 2023
[3] There are four drugs in use for treating DMO: Lucentis (ranibizumab), Eylea (aflibercept) Beovu (Brolucizumab) and Vabysmo (faricimab). They act on the blood ...
[4] Dec 11, 2023
[5] Jan 11, 2023 — Anti-VEGF drugs reduce the growth of new blood vessels. This can prevent people with wet macular degeneration from developing unusual blood ...
[6] Nov 9, 2021 — An experimental drug called CY-09 has been found to block the inflammatory process that drives dry AMD by binding to a molecule called NLRP3.
[7] Feb 21, 2023 — Some medicines, called anti-VEGF drugs, may help stop the growth of new blood vessels. These medicines block the effects of growth signals the ...
[8] Feb 20, 2024
Recommended Medications
- Lucentis (ranibizumab)
- Eylea (aflibercept)
- Beovu (Brolucizumab)
- Vabysmo (faricimab)
- CY-09
- Pegcetacoplan (Syfovre)
- IZERVAY⢠(formerly Zimura)
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnosis of Retinal Macular Dystrophy
Retinal macular dystrophies are a group of disorders characterized by bilateral symmetrical central visual loss. Differential diagnosis is crucial to avoid misdiagnosis and ensure timely treatment, if possible.
Common Differential Diagnoses:
- Age-related macular degeneration (AMD): A leading cause of blindness in older adults, AMD can be confused with retinal macular dystrophies due to similar symptoms.
- Stargardt disease: An inherited condition that affects the retina and can be mistaken for pattern dystrophies or multifocal pattern dystrophy.
- Best disease: A rare genetic disorder that causes progressive vision loss, often misdiagnosed as adult vitelliform macular dystrophy.
- Central serous chorioretinopathy: A condition characterized by fluid accumulation under the retina, which can be mistaken for retinal pigment epithelial changes secondary to central serous chorioretinopathy.
Other Differential Diagnoses:
- Gyrate atrophy: An autosomal-recessive dystrophy that affects the choroid and retina.
- Doyne honeycomb retinal dystrophy (malattia leventinese): A dominantly inherited condition characterized by small, discrete drusen radiating from the center of the fovea.
- Pigment epithelial detachment: A condition where the retinal pigment epithelium separates from the underlying choroid.
Key Considerations:
- Genetic testing: Can help distinguish between different forms of macular dystrophies and other conditions.
- Electroretinography: A non-invasive test that can aid in differential diagnosis.
- Fundus appearance: The characteristic fundus appearance of each condition is crucial for accurate diagnosis.
References:
- [1] Macular degeneration is primarily an age-related retinal condition. There are two types of macular degeneration — wet and dry. You may lose central vision, [8].
- [2] Each retinal dystrophy phenotype is often confused with other genetic or acquired disorders. Misdiagnosis is common and must be avoided, as it has a great bearing on genetic and prognostic counseling, [1].
- [3] The differential diagnosis of non-neovascular ARMD includes retinal pigment epithelial changes secondary to central serous chorioretinopathy, [6].
- [4] A key differential for multifocal pattern dystrophy is Stargardt disease due to the similar appearance of the flecks in the macula and beyond, [11].
Additional Differential Diagnoses
- Central serous chorioretinopathy
- Pigment epithelial detachment
- Stargardt disease
- Doyne honeycomb retinal dystrophy
- disease
- macular degeneration
- gyrate atrophy
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0070438
- core#notation
- DOID:0070438
- oboInOwl#hasDbXref
- MIM:PS136550
- core#exactMatch
- MIM:PS136550
- IAO_0000115
- A macular degeneration characterized by non-progression or slow progression and drusen-like deposits in varying degrees.
- oboInOwl#hasExactSynonym
- MCDR
- rdf-schema#label
- retinal macular dystrophy
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_0070517
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000147
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_2310
- owl#annotatedSource
- t349812
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.